A Phase 2 Dose-finding Study of TAK-272 in Participants With Type 2 Diabetes Mellitus and Microalbuminuria

PHASE2CompletedINTERVENTIONAL
Enrollment

415

Participants

Timeline

Start Date

October 16, 2014

Primary Completion Date

August 18, 2016

Study Completion Date

August 18, 2016

Conditions
Type 2 Diabetes Mellitus and Microalbuminuria
Interventions
DRUG

TAK-272

TAK-272 tablets

DRUG

TAK-272 Placebo

TAK-272 placebo-matching tablets

DRUG

Candesartan cilexetil

Candesartan cilexetil tablets

DRUG

Candesartan cilexetil Placebo

Candesartan cilexetil placebo-matching tablets

Trial Locations (68)

Unknown

Nagoya

Chiba

Kisarazu-shi

Fukuoka

Fukutsu-shi

Kitakyuushu-shi

Kouriyama-shi

Anchu-shi

Ota-shi

Ishikari-shi

Obihiro-shi

Sapporo

Kobe

Nishinomiya-shi

Moriya-shi

Naka

Koga

Koga-shi

Mito

Takamatsu

Ebina-shi

Hiratsuka-shi

Kawasaki-shi

Miura-shi

Shounann-shi

Yokohama

Kochi

Kumamoto

Yatsushiro-shi

Kyoto

Uji-shi

Sendai

Miyazaki

Azumino-shi

Matsumoto-shi

Nakano-shi

Sasebo-shi

Kasaoka-shi

Kurashiki-shi

Naha

Shimajiri-gun

Tomigusuku-shi

Kashiwara-shi

Matsubara-shi

Neyagawa

Osaka

Suita-shi

Tondabayashi-shi

Kawagoe-shi

Kyuki-shi

Saitama-shi

Hamamatsu

Shizuoka

Koyama-shi

Shimono-shi

Chiyoda-ku

Chuo-ku

Hachioji-shi

Hino-shi

Itabashi-ku

Katsushika-ku

Nerima-ku

Ōta-ku

Shibuya-ku

Shinagawa-ku

Shinjuku-ku

Shinjyuku-ku

Ube-shi

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Takeda

INDUSTRY